CANCER

British PM May calls on health, tech sectors to work on cancer

British PM May calls on health, tech sectors to work on cancer

Published 20/05/2018

LONDON (Reuters) - Prime Minister Theresa May will call on Britain’s health service, charities and artificial intelligence sector to work together to better identify patients [more…]

Obamacare tied to earlier cancer detection in young women

Obamacare tied to earlier cancer detection in young women

Published 18/05/2018

(Reuters Health) - Under the Affordable Care Act (ACA) provision allowing adult children to stay on their parents’ health insurance policy until age 26, young [more…]

J&J defends itself in trial over baby powder asbestos claims

J&J defends itself in trial over baby powder asbestos claims

Published 15/05/2018

(Reuters) - A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of a woman due to her [more…]

Hair-straightening products contain potentially toxic mix

Hair-straightening products contain potentially toxic mix

Published 14/05/2018

(Reuters Health) - Hair products used primarily by black women and children contain a host of hazardous chemicals, a new study shows. The findings could [more…]

Overactive immune response linked to hair graying

Overactive immune response linked to hair graying

Published 03/05/2018

(Reuters Health) - An overactive immune response, which can occur with viral infections, could result in sudden hair graying, according to research in mice. The [more…]

Too many cancer drugs? Crowded market gives investors pause

Too many cancer drugs? Crowded market gives investors pause

Published 02/05/2018

LONDON (Reuters) - In London’s world-famous Great Ormond Street children’s hospital, Dr. Karin Straathof is excited about a new cell-based medicine that offers hope for [more…]

AbbVie’s beat fueled by demand for Humira, Hep C drugs

AbbVie’s beat fueled by demand for Humira, Hep C drugs

Published 26/04/2018

(Reuters) - AbbVie Inc reported a better-than-expected quarterly profit on Thursday, on higher sales of its rheumatoid arthritis treatment Humira and its Hepatitis C drugs, [more…]

J&J Baby Powder litigation takes new focus with asbestos claims

J&J Baby Powder litigation takes new focus with asbestos claims

Published 16/04/2018

NEW YORK (Reuters) - A $117 million verdict against Johnson & Johnson (JNJ.N) and a supplier in favor of a man who said his asbestos-related [more…]

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Published 16/04/2018

LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to [more…]

As cancer drug prices climb, value not keeping pace

As cancer drug prices climb, value not keeping pace

Published 12/04/2018

(Reuters Health) - The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients [more…]